ARS Pharmaceuticals, Inc.
SPRY- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001671858
No open-market purchases or sales by ARS Pharmaceuticals, Inc. insiders were filed in the last 90 days; 208 institutions reported holding it in 13F filings for Q2 2026, worth $726.0M in total; Third Point is the only superinvestor holding it.
13F holders, Q2 2025
Institutional positions in ARS Pharmaceuticals, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 188
- +6 vs. Q1 2025
- Shares held
- 84.5M
- +8.36M (+11.0%) vs. Q1 2025
- Total value
- $1.48B
- +$516.9M (+53.9%) vs. Q1 2025
- New holders
- 28
- 81 more added
- Sold out
- 22
- 47 more reduced
2 institutions that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SPRY on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 208 | $726.0M |
| Q1 2026 | 203 | $757.5M |
| Q4 2025 | 191 | $1.05B |
| Q3 2025 | 188 | $840.4M |
| Q2 2025 | 188 | $1.48B |
| Q1 2025 | 184 | $958.9M |
| Q4 2024 | 166 | $752.3M |
| Q3 2024 | 151 | $928.4M |
| Q2 2024 | 115 | $533.0M |
| Q1 2024 | 113 | $612.1M |
| Q4 2023 | 100 | $358.5M |
| Q3 2023 | 97 | $251.6M |
| Q2 2023 | 92 | $369.0M |
| Q1 2023 | 90 | $347.7M |
| Q4 2022 | 73 | $427.9M |
| Q3 2022 | 61 | $160.4M |
| Q2 2022 | 64 | $110.5M |
| Q1 2022 | 70 | $94.7M |
| Q4 2021 | 72 | $200.5M |
| Q3 2021 | 74 | $288.4M |
| Q2 2021 | 76 | $864.6M |
| Q1 2021 | 68 | $1.21B |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding ARS Pharmaceuticals, Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −18,583−100.0% | Sold out |
| TFG Advisers LLC | 0 | $0 | 0.00% | −12,291−100.0% | Sold out |
| Quadrature Capital Ltd | 0 | $0 | 0.00% | −10,974−100.0% | Sold out |
| CIBC World Markets Corp | 0 | $0 | 0.00% | −10,920−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −10,771−100.0% | Sold out |
| Quadrant Capital Group LLC | 0 | $0 | 0.00% | −347−100.0% | Sold out |
| Coldstream Capital Management Inc | 0 | $0 | 0.00% | −70−100.0% | Sold out |
| CoreCap Advisors, LLC | 0 | $0 | 0.00% | −41−100.0% | Sold out |
| Parallel Advisors, LLC | 0 | $0 | 0.00% | −38−100.0% | Sold out |
| Stephens Consulting, LLC | 0 | $0 | 0.00% | −30−100.0% | Sold out |
| Kodai Capital Management LP | – | – | – | – | Not filed |
| Lindbrook Capital, LLC | – | – | – | – | Not filed |